Pub Date : 2026-02-02eCollection Date: 2026-02-01DOI: 10.7759/cureus.102852
Amaar Aamery, Salim AlMaashani, Salim Tabook, Suma Jacob
Acute appendicitis is widely recognized as the leading cause of acute abdominal pain in patients seeking hospital treatment. The standard of care and golden approach has traditionally involved performing an appendicectomy, which nowadays is more often performed using laparoscopic techniques. As with any laparoscopic procedure, there is a risk of iatrogenic organ injury, particularly during trocar insertion; one such organ at risk is the urinary bladder (0.17-0.73%). Most reported cases of urinary bladder injuries occur due to trocar insertion in the suprapubic area. In this report, we present a case of a patient with an occult bladder injury diagnosed postoperatively on day 3 via creatinine level in drain fluid after undergoing a laparoscopic appendicectomy. We also include a review of the literature regarding the presentation, diagnosis, and management of this complication.
{"title":"A Rare Complication of Bladder Injury Following Laparoscopic Appendectomy: A Case Report and Literature Review.","authors":"Amaar Aamery, Salim AlMaashani, Salim Tabook, Suma Jacob","doi":"10.7759/cureus.102852","DOIUrl":"10.7759/cureus.102852","url":null,"abstract":"<p><p>Acute appendicitis is widely recognized as the leading cause of acute abdominal pain in patients seeking hospital treatment. The standard of care and golden approach has traditionally involved performing an appendicectomy, which nowadays is more often performed using laparoscopic techniques. As with any laparoscopic procedure, there is a risk of iatrogenic organ injury, particularly during trocar insertion; one such organ at risk is the urinary bladder (0.17-0.73%). Most reported cases of urinary bladder injuries occur due to trocar insertion in the suprapubic area. In this report, we present a case of a patient with an occult bladder injury diagnosed postoperatively on day 3 via creatinine level in drain fluid after undergoing a laparoscopic appendicectomy. We also include a review of the literature regarding the presentation, diagnosis, and management of this complication.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102852"},"PeriodicalIF":1.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-02-01DOI: 10.7759/cureus.102841
P B Anirudh, Prashanth Babu, Anil K Sakalecha
Objective: The objective of this study was to compare the diagnostic accuracy of ultrasonography and computed tomography (CT) in the diagnosis of nasal bone fractures (NBFs) and to assess their clinical utility in the context of current evidence-based recommendations.
Methodology: This prospective analytical study was conducted in the Department of Otorhinolaryngology between January 2021 and December 2022, encompassing 126 patients with clinically diagnosed NBFs who provided informed written consent. Ultrasonographic and CT imaging were used to detect and characterize fractures. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of ultrasonography and CT in identifying NBFs were calculated with 95% confidence intervals (CIs).
Results: Among 126 patients (mean age: 38.4 years; 90.5% male), clinical examination identified NBFs in all cases. Ultrasonography detected 121 fractures (accuracy: 96.0%), while CT detected 125 fractures (accuracy: 99.2%). Sensitivity of ultrasonography was 88.57% (95% CI: 83.2-92.5%) compared to the CT sensitivity of 97.3% (95% CI: 94.8-98.9%). Both modalities demonstrated 100% specificity. McNemar's test demonstrated a statistically significant difference in sensitivity between CT and ultrasonography (p = 0.008). CT showed superior sensitivity in detecting undisplaced fractures (35 vs. 31 cases, p = 0.047), with no significant difference for displaced or comminuted fractures (p > 0.05).
Conclusion: While CT demonstrates superior sensitivity, particularly for undisplaced NBFs, ultrasonography offers a valuable non-ionizing alternative for initial fracture assessment in appropriate clinical contexts. Both modalities demonstrated high sensitivity for displaced fractures. However, the choice of imaging should balance the superior accuracy of CT against the safety and accessibility of USG, with awareness of operator dependency. Further prospective studies with multi-center participation and varied operator experience levels are warranted to determine optimal imaging strategies.
{"title":"Comparative Study of Ultrasonography and Computed Tomography in the Diagnosis of Nasal Bone Fractures.","authors":"P B Anirudh, Prashanth Babu, Anil K Sakalecha","doi":"10.7759/cureus.102841","DOIUrl":"10.7759/cureus.102841","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to compare the diagnostic accuracy of ultrasonography and computed tomography (CT) in the diagnosis of nasal bone fractures (NBFs) and to assess their clinical utility in the context of current evidence-based recommendations.</p><p><strong>Methodology: </strong>This prospective analytical study was conducted in the Department of Otorhinolaryngology between January 2021 and December 2022, encompassing 126 patients with clinically diagnosed NBFs who provided informed written consent. Ultrasonographic and CT imaging were used to detect and characterize fractures. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of ultrasonography and CT in identifying NBFs were calculated with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Among 126 patients (mean age: 38.4 years; 90.5% male), clinical examination identified NBFs in all cases. Ultrasonography detected 121 fractures (accuracy: 96.0%), while CT detected 125 fractures (accuracy: 99.2%). Sensitivity of ultrasonography was 88.57% (95% CI: 83.2-92.5%) compared to the CT sensitivity of 97.3% (95% CI: 94.8-98.9%). Both modalities demonstrated 100% specificity. McNemar's test demonstrated a statistically significant difference in sensitivity between CT and ultrasonography (p = 0.008). CT showed superior sensitivity in detecting undisplaced fractures (35 vs. 31 cases, p = 0.047), with no significant difference for displaced or comminuted fractures (p > 0.05).</p><p><strong>Conclusion: </strong>While CT demonstrates superior sensitivity, particularly for undisplaced NBFs, ultrasonography offers a valuable non-ionizing alternative for initial fracture assessment in appropriate clinical contexts. Both modalities demonstrated high sensitivity for displaced fractures. However, the choice of imaging should balance the superior accuracy of CT against the safety and accessibility of USG, with awareness of operator dependency. Further prospective studies with multi-center participation and varied operator experience levels are warranted to determine optimal imaging strategies.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102841"},"PeriodicalIF":1.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146114888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-02-01DOI: 10.7759/cureus.102863
Saeed Javid, Dace Dimante, Soha Zahid, Ahmed Eweiss, Alireza Shoakazemi
Craniopharyngiomas are benign suprasellar tumours that can present with symptoms of raised intracranial pressure, visual impairment, or endocrine dysfunction. They are classified into the more common adamantinomatous and less common papillary tumours. Cystic variants may cause obstructive hydrocephalus, necessitating urgent intervention. This video case-based review presents the case of a 61-year-old male who presented with a two-month history of headaches, cognitive decline, and visual changes. Imaging revealed a large 2.8 x 2.2 x 2.2 cm suprasellar mass with cystic components extending into the third ventricle - consistent with a craniopharyngioma, causing bilateral foraminal obstruction and acute hydrocephalus. An urgent right frontal endoscopic septum pellucidostomy, cyst drainage, and ventriculoperitoneal shunt insertion achieved rapid symptomatic relief. Histopathology confirmed a World Health Organization (WHO) Grade 1 adamantinomatous craniopharyngioma. Following neurological stabilisation, a planned second-stage extended transsphenoidal resection achieved near-total removal. Postoperative radiotherapy was delivered to the tumour residuum. Endocrine sequelae, including hypopituitarism and diabetes insipidus, were managed with hormone replacement. At one-year follow-up, the patient remained radiologically stable with no recurrence. A review of current literature further supports neuroendoscopic transventricular cyst aspiration as a temporising measure in cyst-dominant craniopharyngiomas, particularly in the setting of acute hydrocephalus. This strategy offers rapid decompression, symptom relief, facilitating safer, elective definitive surgery. However, as a sole intervention, it is rarely curative, and recurrence risk remains high without subsequent resection and/or radiotherapy. A planned, two-stage approach combining neuroendoscopic decompression with definitive tumour control represents a safe and effective management strategy for giant cystic craniopharyngiomas.
颅咽管瘤是良性鞍上肿瘤,可表现为颅内压升高、视力损害或内分泌功能障碍。它们分为较常见的金刚瘤和较不常见的乳头状肿瘤。囊性变异可引起梗阻性脑积水,需要紧急干预。本视频以病例为基础回顾了一个61岁男性的病例,他表现为两个月的头痛,认知能力下降和视力变化。影像学显示一个巨大的2.8 x 2.2 x 2.2 cm的鞍上肿块,囊性成分延伸至第三脑室,符合颅咽管瘤,引起双侧椎间孔阻塞和急性脑积水。紧急右额叶内窥镜下鼻中隔透明造口术、囊肿引流和脑室-腹膜分流术的插入迅速缓解了症状。组织病理学证实为世界卫生组织(WHO)一级硬瘤性颅咽管瘤。神经系统稳定后,计划进行第二阶段扩展经蝶窦切除术,几乎完全切除。术后对肿瘤残端进行放疗。内分泌后遗症,包括垂体功能低下和尿崩症,用激素替代治疗。在一年的随访中,患者放射学稳定,无复发。对当前文献的回顾进一步支持神经内窥镜经脑室囊肿抽吸作为囊肿显性颅咽管瘤的一种临时措施,特别是在急性脑积水的情况下。该策略提供快速减压,缓解症状,促进更安全,选择性最终手术。然而,作为唯一的干预措施,它很少能治愈,并且不进行后续切除和/或放疗,复发风险仍然很高。一个有计划的,两阶段的方法结合神经内窥镜减压和明确的肿瘤控制是一种安全有效的治疗巨大囊性颅咽管瘤的策略。
{"title":"Neuroendoscopic Trans-ventricular Cyst Drainage Prior to Tumour Resection Using a Two-Staged Approach for Cystic Craniopharyngioma: A Case Report and Literature Review.","authors":"Saeed Javid, Dace Dimante, Soha Zahid, Ahmed Eweiss, Alireza Shoakazemi","doi":"10.7759/cureus.102863","DOIUrl":"10.7759/cureus.102863","url":null,"abstract":"<p><p>Craniopharyngiomas are benign suprasellar tumours that can present with symptoms of raised intracranial pressure, visual impairment, or endocrine dysfunction. They are classified into the more common adamantinomatous and less common papillary tumours. Cystic variants may cause obstructive hydrocephalus, necessitating urgent intervention. This video case-based review presents the case of a 61-year-old male who presented with a two-month history of headaches, cognitive decline, and visual changes. Imaging revealed a large 2.8 x 2.2 x 2.2 cm suprasellar mass with cystic components extending into the third ventricle - consistent with a craniopharyngioma, causing bilateral foraminal obstruction and acute hydrocephalus. An urgent right frontal endoscopic septum pellucidostomy, cyst drainage, and ventriculoperitoneal shunt insertion achieved rapid symptomatic relief. Histopathology confirmed a World Health Organization <i>(</i>WHO) Grade 1 adamantinomatous craniopharyngioma. Following neurological stabilisation, a planned second-stage extended transsphenoidal resection achieved near-total removal. Postoperative radiotherapy was delivered to the tumour residuum. Endocrine sequelae, including hypopituitarism and diabetes insipidus, were managed with hormone replacement. At one-year follow-up, the patient remained radiologically stable with no recurrence. A review of current literature further supports neuroendoscopic transventricular cyst aspiration as a temporising measure in cyst-dominant craniopharyngiomas, particularly in the setting of acute hydrocephalus. This strategy offers rapid decompression, symptom relief, facilitating safer, elective definitive surgery. However, as a sole intervention, it is rarely curative, and recurrence risk remains high without subsequent resection and/or radiotherapy. A planned, two-stage approach combining neuroendoscopic decompression with definitive tumour control represents a safe and effective management strategy for giant cystic craniopharyngiomas.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102863"},"PeriodicalIF":1.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02eCollection Date: 2026-02-01DOI: 10.7759/cureus.102811
Bhavna Shah, Tarani Sai Prasanth Grandhi, Zara Syeda, Esther Idowu, Nanda Chetty, Amit Sharma
Background: Accurate preoperative blood grouping and antibody screening are critical for trauma and orthopaedic (T&O) surgery. Group and Save (G&S) samples are frequently rejected due to labelling discrepancies, incomplete documentation, or sample quality issues. Such rejections delay surgery, increase patient discomfort from repeated venepuncture, and generate avoidable financial and operational burdens. This audit assessed the frequency, underlying causes, and financial implications of rejected GS samples for T&O patients in the Accident and Emergency (A&E) department and developed targeted recommendations to minimise error rates.
Methods: A retrospective clinical audit was conducted at the Luton and Dunstable Hospital NHS Foundation Trust, United Kingdom, encompassing all patients admitted with neck of femur (NOF) fractures between September 2024 and March 2025. Laboratory information system data and request forms were reviewed to identify rejected samples, categorise causes of rejection, and determine the staff group responsible for collection. Cost estimates were calculated using the hospital's local pathology finance reports. A follow-up re-audit was conducted after implementing the initial audit's recommendations, from July to October 2025.
Results: Of 171 G&S samples, 64 (37.4%) were rejected. The majority (62.5%, n=40) were taken by A&E staff. Predominant causes were absent signatures, missing date/time, mismatched identifiers, and sample integrity issues (haemolysis/underfilling). Approximately 20% (n=13) of affected patients required ≥2 repeat samples. The direct cost per rejected sample ranged from £12 to £80. After interventions, a re-audit of 84 samples showed the rejection rate fell to 16.6% (n=14).
Conclusions: Sample rejection in A&E is a preventable source of perioperative inefficiency. Most errors stemmed from documentation/labelling lapses. Implementing standardised bedside labelling, electronic order validation, and mandatory competency refreshers supported by a G&S checklist substantially reduced rejection rates. These measures optimise workflow, reduce costs, and enhance patient safety.
{"title":"Audit of Group and Save Sample Rejection in Fractured Neck of Femur Patients at a United Kingdom District Hospital.","authors":"Bhavna Shah, Tarani Sai Prasanth Grandhi, Zara Syeda, Esther Idowu, Nanda Chetty, Amit Sharma","doi":"10.7759/cureus.102811","DOIUrl":"10.7759/cureus.102811","url":null,"abstract":"<p><strong>Background: </strong> Accurate preoperative blood grouping and antibody screening are critical for trauma and orthopaedic (T&O) surgery. Group and Save (G&S) samples are frequently rejected due to labelling discrepancies, incomplete documentation, or sample quality issues. Such rejections delay surgery, increase patient discomfort from repeated venepuncture, and generate avoidable financial and operational burdens. This audit assessed the frequency, underlying causes, and financial implications of rejected GS samples for T&O patients in the Accident and Emergency (A&E) department and developed targeted recommendations to minimise error rates.</p><p><strong>Methods: </strong> A retrospective clinical audit was conducted at the Luton and Dunstable Hospital NHS Foundation Trust, United Kingdom, encompassing all patients admitted with neck of femur (NOF) fractures between September 2024 and March 2025. Laboratory information system data and request forms were reviewed to identify rejected samples, categorise causes of rejection, and determine the staff group responsible for collection. Cost estimates were calculated using the hospital's local pathology finance reports. A follow-up re-audit was conducted after implementing the initial audit's recommendations, from July to October 2025.</p><p><strong>Results: </strong> Of 171 G&S samples, 64 (37.4%) were rejected. The majority (62.5%, n=40) were taken by A&E staff. Predominant causes were absent signatures, missing date/time, mismatched identifiers, and sample integrity issues (haemolysis/underfilling). Approximately 20% (n=13) of affected patients required ≥2 repeat samples. The direct cost per rejected sample ranged from £12 to £80. After interventions, a re-audit of 84 samples showed the rejection rate fell to 16.6% (n=14).</p><p><strong>Conclusions: </strong> Sample rejection in A&E is a preventable source of perioperative inefficiency. Most errors stemmed from documentation/labelling lapses. Implementing standardised bedside labelling, electronic order validation, and mandatory competency refreshers supported by a G&S checklist substantially reduced rejection rates. These measures optimise workflow, reduce costs, and enhance patient safety.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102811"},"PeriodicalIF":1.3,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyaluronic acid (HA) currently maintains a favorable safety profile in the field of aesthetic medicine. However, severe acute hypersensitivity reactions may occur, clinically defined as angioedema. This condition typically presents immediately after HA injection, with marked swelling, pain, and evident tissue distress secondary to edema and local vascular physiological alterations. These events are more frequently observed in the lips, and although reported cases are scarce, most involve this anatomical location. The etiology of this uncommon complication is not fully understood. Proposed mechanisms include trace protein impurities within HA preparations, as well as the role of CD44-expressing mast cells, which exhibit strong adherence to tissue-bound HA. We present a case report of a patient who developed labial angioedema following HA injection, clinically associated with both viral and bacterial infection. The clinical presentation, diagnostic workup, therapeutic approach, and clinical outcome are described.
{"title":"Labial Angioedema and Bacterial and Viral Infection Following Hyaluronic Acid Injection.","authors":"Macarena Olivares, Victor Mercado","doi":"10.7759/cureus.102791","DOIUrl":"10.7759/cureus.102791","url":null,"abstract":"<p><p>Hyaluronic acid (HA) currently maintains a favorable safety profile in the field of aesthetic medicine. However, severe acute hypersensitivity reactions may occur, clinically defined as angioedema. This condition typically presents immediately after HA injection, with marked swelling, pain, and evident tissue distress secondary to edema and local vascular physiological alterations. These events are more frequently observed in the lips, and although reported cases are scarce, most involve this anatomical location. The etiology of this uncommon complication is not fully understood. Proposed mechanisms include trace protein impurities within HA preparations, as well as the role of CD44-expressing mast cells, which exhibit strong adherence to tissue-bound HA. We present a case report of a patient who developed labial angioedema following HA injection, clinically associated with both viral and bacterial infection. The clinical presentation, diagnostic workup, therapeutic approach, and clinical outcome are described.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102791"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chiari II malformation is commonly associated with hydrocephalus requiring early cerebrospinal fluid (CSF) diversion and may coexist with complex supratentorial developmental abnormalities. As a result, patients with severe congenital structural brain anomalies and long-term ventriculoperitoneal (VP) shunting often experience neurodevelopmental impairment and are at increased risk of epilepsy. We report a 17-year-old girl with Chiari II malformation, repaired myelomeningocele, and ventriculoperitoneal shunting since birth (revision at five years of age), demonstrating marked ventricular improvement over a 16-year interval and a prolonged seizure-free interval despite severe congenital supratentorial malformations.
{"title":"Sixteen-Year Interval CT Comparison in Chiari II Malformation After Early Ventriculoperitoneal Shunting: Marked Ventricular Improvement and a Prolonged Seizure-Free Interval.","authors":"Ahmed H Khird, Alaa A Alotaibi","doi":"10.7759/cureus.102802","DOIUrl":"10.7759/cureus.102802","url":null,"abstract":"<p><p>Chiari II malformation is commonly associated with hydrocephalus requiring early cerebrospinal fluid (CSF) diversion and may coexist with complex supratentorial developmental abnormalities. As a result, patients with severe congenital structural brain anomalies and long-term ventriculoperitoneal (VP) shunting often experience neurodevelopmental impairment and are at increased risk of epilepsy. We report a 17-year-old girl with Chiari II malformation, repaired myelomeningocele, and ventriculoperitoneal shunting since birth (revision at five years of age), demonstrating marked ventricular improvement over a 16-year interval and a prolonged seizure-free interval despite severe congenital supratentorial malformations.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102802"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maxim J Barnett, Maria deMelo, Maria Rego, Carlo Casipit
Teprotumumab is a medication for thyroid eye disease. We conducted a review of studies assessing teprotumumab for thyroid eye disease treatment from MEDLINE (Medical Literature Analysis and Retrieval System Online) and CINHAL (Cumulative Index to Nursing and Allied Health Literature) from inception to September 20, 2025. The outcome of interest was hearing impairment. We included nine studies (four randomized controlled trials and five observational studies). The randomized controlled trials included 153 teprotumumab-treated patients. Using both broad and strict definitions of hearing loss, teprotumumab continued to demonstrate a statistically significant increased risk of hearing impairment (Broad: risk ratio (RR) 3.57, 95% CI 1.27-9.97; Strict: RR 5.23, 95% CI 1.40-19.57). Observational studies included over 2,000 patients treated with teprotumumab. Using the broad definition, the RR amongst observational studies was 2.78 (95% CI, 2.38-3.24); using the strict definition, the RR amongst observational studies was 2.76 (95% CI, 2.30-3.31). Sensitivity analyses were performed, with results remaining statistically significant, without heterogeneity or publication bias. Teprotumumab is associated with hearing impairment using broad and strict definitions, consistent amongst both RCTs and observational studies. Further research is required to address potential treatment options, the likelihood of recurrence with retreatment, and the chance of recovery.
Teprotumumab是一种治疗甲状腺眼病的药物。我们对MEDLINE(医学文献分析和检索系统在线)和CINHAL(护理和相关健康文献累积索引)从成立到2025年9月20日评估teprotumumab治疗甲状腺眼病的研究进行了回顾。结果是听力受损。我们纳入了9项研究(4项随机对照试验和5项观察性研究)。随机对照试验包括153例接受teprotumumab治疗的患者。使用广义和严格的听力损失定义,teprotumumab继续显示具有统计学意义的听力损害风险增加(广义:风险比(RR) 3.57, 95% CI 1.27-9.97;严格:RR 5.23, 95% CI 1.40-19.57)。观察性研究包括超过2000名接受teprotumumab治疗的患者。使用广义定义,观察性研究的RR为2.78 (95% CI, 2.38-3.24);使用严格定义,观察性研究的RR为2.76 (95% CI, 2.30-3.31)。进行敏感性分析,结果仍然具有统计学意义,没有异质性或发表偏倚。Teprotumumab与听力障碍相关的定义广泛而严格,在随机对照试验和观察性研究中都是一致的。需要进一步的研究来解决潜在的治疗方案、再治疗复发的可能性和恢复的机会。
{"title":"Association Between Teprotumumab and Hearing Impairment: A Meta-Analysis.","authors":"Maxim J Barnett, Maria deMelo, Maria Rego, Carlo Casipit","doi":"10.7759/cureus.102775","DOIUrl":"10.7759/cureus.102775","url":null,"abstract":"<p><p>Teprotumumab is a medication for thyroid eye disease. We conducted a review of studies assessing teprotumumab for thyroid eye disease treatment from MEDLINE (Medical Literature Analysis and Retrieval System Online) and CINHAL (Cumulative Index to Nursing and Allied Health Literature) from inception to September 20, 2025. The outcome of interest was hearing impairment. We included nine studies (four randomized controlled trials and five observational studies). The randomized controlled trials included 153 teprotumumab-treated patients. Using both broad and strict definitions of hearing loss, teprotumumab continued to demonstrate a statistically significant increased risk of hearing impairment (Broad: risk ratio (RR) 3.57, 95% CI 1.27-9.97; Strict: RR 5.23, 95% CI 1.40-19.57). Observational studies included over 2,000 patients treated with teprotumumab. Using the broad definition, the RR amongst observational studies was 2.78 (95% CI, 2.38-3.24); using the strict definition, the RR amongst observational studies was 2.76 (95% CI, 2.30-3.31). Sensitivity analyses were performed, with results remaining statistically significant, without heterogeneity or publication bias. Teprotumumab is associated with hearing impairment using broad and strict definitions, consistent amongst both RCTs and observational studies. Further research is required to address potential treatment options, the likelihood of recurrence with retreatment, and the chance of recovery.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102775"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12861491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmad Haj Hussein, Charbel Ghosn, Richard Feghaly, Mariana Helou
Renal infarction is an uncommon and frequently underdiagnosed condition caused by the acute interruption of renal arterial blood flow. Its clinical presentation often mimics renal colic, and laboratory findings may be nonspecific, leading to delayed or missed diagnosis. Although embolic and thrombotic etiologies are most commonly implicated, idiopathic renal infarction remains rare. We report the case of a 45-year-old previously healthy man who presented with sudden-onset left flank pain radiating to the left upper quadrant, associated with nausea and abdominal discomfort. He had no history of cardiovascular disease, trauma, thrombophilia, or autoimmune disorders. Physical examination revealed left costovertebral angle tenderness. Laboratory evaluation demonstrated mild leukocytosis and microscopic hematuria without inflammatory marker elevation. Contrast-enhanced computed tomography of the abdomen and pelvis revealed multifocal wedge-shaped hypoenhancing areas in the left kidney consistent with renal infarction, secondary to filling defects in the main left renal artery. An accessory left renal artery supplying the inferior pole was noted. Autoimmune and thrombophilia workup was negative. The patient was treated with anticoagulation using unfractionated heparin followed by apixaban. Follow-up imaging demonstrated partial recanalization of the renal artery with no progression of infarction and preserved renal function. Idiopathic renal infarction should be considered in patients presenting with acute flank pain when initial evaluation for nephrolithiasis is negative. Early contrast-enhanced imaging is crucial for diagnosis. Prompt anticoagulation can prevent progression and preserve renal function.
{"title":"Idiopathic Renal Infarct in a Healthy Adult With an Accessory Renal Artery: A Case Report.","authors":"Ahmad Haj Hussein, Charbel Ghosn, Richard Feghaly, Mariana Helou","doi":"10.7759/cureus.102806","DOIUrl":"10.7759/cureus.102806","url":null,"abstract":"<p><p>Renal infarction is an uncommon and frequently underdiagnosed condition caused by the acute interruption of renal arterial blood flow. Its clinical presentation often mimics renal colic, and laboratory findings may be nonspecific, leading to delayed or missed diagnosis. Although embolic and thrombotic etiologies are most commonly implicated, idiopathic renal infarction remains rare. We report the case of a 45-year-old previously healthy man who presented with sudden-onset left flank pain radiating to the left upper quadrant, associated with nausea and abdominal discomfort. He had no history of cardiovascular disease, trauma, thrombophilia, or autoimmune disorders. Physical examination revealed left costovertebral angle tenderness. Laboratory evaluation demonstrated mild leukocytosis and microscopic hematuria without inflammatory marker elevation. Contrast-enhanced computed tomography of the abdomen and pelvis revealed multifocal wedge-shaped hypoenhancing areas in the left kidney consistent with renal infarction, secondary to filling defects in the main left renal artery. An accessory left renal artery supplying the inferior pole was noted. Autoimmune and thrombophilia workup was negative. The patient was treated with anticoagulation using unfractionated heparin followed by apixaban. Follow-up imaging demonstrated partial recanalization of the renal artery with no progression of infarction and preserved renal function. Idiopathic renal infarction should be considered in patients presenting with acute flank pain when initial evaluation for nephrolithiasis is negative. Early contrast-enhanced imaging is crucial for diagnosis. Prompt anticoagulation can prevent progression and preserve renal function.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102806"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Olga Vampertzi, Eleni Vouxinou, Asimina Mataftsi, Fotini Goutsaridou, Maria Fotoulaki, Dimitrios Zafeiriou
Idiopathic intracranial hypertension (IIH) is a rare neurological syndrome characterized by increased intracranial pressure (>28 cm H₂O in children), in the absence of intracranial space-occupying lesions, and with normal cerebrospinal fluid (CSF) composition. Optic perineuritis (OPN) is an orbital inflammatory disease confined to the optic nerve sheath. We report a case of concurrent IIH and bilateral OPN in a previously healthy child. A 13-year-old male, with normal body mass index, presented with diplopia, visual blurriness without ocular pain, and occipital headache. Neurological examination was notable only for right sixth nerve palsy. Ophthalmological assessment revealed bilateral papilledema. Brain and spinal cord magnetic resonance imaging (MRI) and computed tomography (CT) scans demonstrated bilateral optic nerve perineuritis. Lumbar puncture showed an opening pressure of 98 cm H₂O, with normal CSF composition. The patient was treated with acetazolamide and corticosteroids, resulting in marked clinical improvement and complete restoration of vision at two-month follow-up. The concurrent occurrence of IIH and bilateral OPN is extremely rare, particularly in pediatric patients. To our knowledge, this is the first reported case in a child. Recognition of this dual pathology is essential for timely diagnosis and effective treatment.
特发性颅内高压(Idiopathic intracranial hypertension, IIH)是一种罕见的神经系统综合征,其特征是颅内压升高(儿童颅内压为bbbb28 cm H₂O),没有颅内占位性病变,脑脊液(CSF)成分正常。视神经会阴炎(OPN)是一种局限于视神经鞘的眼窝炎性疾病。我们报告一个病例并发IIH和双边OPN在一个以前健康的儿童。13岁男性,体重指数正常,表现为复视,视力模糊,无眼痛,枕部头痛。神经学检查仅对右侧第六神经麻痹有显著影响。眼科检查显示双侧乳头水肿。脑和脊髓磁共振成像(MRI)和计算机断层扫描(CT)显示双侧视神经周围神经炎。腰椎穿刺显示开口压力98 cm H₂O,脑脊液成分正常。患者给予乙酰唑胺和皮质类固醇治疗,随访2个月,临床明显改善,视力完全恢复。IIH和双侧OPN同时发生是非常罕见的,特别是在儿科患者中。据我们所知,这是首次报道的儿童病例。认识到这种双重病理是必要的及时诊断和有效的治疗。
{"title":"Concurrent Presentation of Idiopathic Intracranial Hypertension and Bilateral Optic Perineuritis in a Young Boy: A Rare Clinical Entity.","authors":"Olga Vampertzi, Eleni Vouxinou, Asimina Mataftsi, Fotini Goutsaridou, Maria Fotoulaki, Dimitrios Zafeiriou","doi":"10.7759/cureus.102792","DOIUrl":"10.7759/cureus.102792","url":null,"abstract":"<p><p>Idiopathic intracranial hypertension (IIH) is a rare neurological syndrome characterized by increased intracranial pressure (>28 cm H₂O in children), in the absence of intracranial space-occupying lesions, and with normal cerebrospinal fluid (CSF) composition. Optic perineuritis (OPN) is an orbital inflammatory disease confined to the optic nerve sheath. We report a case of concurrent IIH and bilateral OPN in a previously healthy child. A 13-year-old male, with normal body mass index, presented with diplopia, visual blurriness without ocular pain, and occipital headache. Neurological examination was notable only for right sixth nerve palsy. Ophthalmological assessment revealed bilateral papilledema. Brain and spinal cord magnetic resonance imaging (MRI) and computed tomography (CT) scans demonstrated bilateral optic nerve perineuritis. Lumbar puncture showed an opening pressure of 98 cm H₂O, with normal CSF composition. The patient was treated with acetazolamide and corticosteroids, resulting in marked clinical improvement and complete restoration of vision at two-month follow-up. The concurrent occurrence of IIH and bilateral OPN is extremely rare, particularly in pediatric patients. To our knowledge, this is the first reported case in a child. Recognition of this dual pathology is essential for timely diagnosis and effective treatment.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102792"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146114872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Remote patient monitoring (RPM) has the potential to replace reactive, clinic-based encounters with preventive, continuous care delivered in patients' homes. However, the adoption of RPM has not kept pace with the global ascendance of telehealth in recent years. This narrative review draws on published literature on RPM since 2010, with an emphasis on barriers to RPM program adoption and implementation in clinical settings. Identified challenges to widespread adoption include data overload, ambiguous clinical responsibility, poor integration into existing workflows, and patient and device usability issues. Though the technology itself is reliable, a clearly defined clinical care model is required to maximise the potential of RPM and prevent overburdening healthcare systems. This narrative review suggests that a protocol-driven model with a tiered escalation plan may be beneficial. Future prospective implementation research is required to evaluate the use of alternative, restructured care models for delivering RPM programs.
{"title":"Remote Patient Monitoring and the Need for a New Care Model: A Narrative Review of Implementation Challenges.","authors":"Goutham V Meda, Ailie H Brennan-Davies","doi":"10.7759/cureus.102803","DOIUrl":"10.7759/cureus.102803","url":null,"abstract":"<p><p>Remote patient monitoring (RPM) has the potential to replace reactive, clinic-based encounters with preventive, continuous care delivered in patients' homes. However, the adoption of RPM has not kept pace with the global ascendance of telehealth in recent years. This narrative review draws on published literature on RPM since 2010, with an emphasis on barriers to RPM program adoption and implementation in clinical settings. Identified challenges to widespread adoption include data overload, ambiguous clinical responsibility, poor integration into existing workflows, and patient and device usability issues. Though the technology itself is reliable, a clearly defined clinical care model is required to maximise the potential of RPM and prevent overburdening healthcare systems. This narrative review suggests that a protocol-driven model with a tiered escalation plan may be beneficial. Future prospective implementation research is required to evaluate the use of alternative, restructured care models for delivering RPM programs.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"18 2","pages":"e102803"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12862263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}